You will receive alerts when there are new announcements on Cereno Scientific AB
Only registered members can use this feature.
Cereno Scientific is developing a new preventive drug that normalizes the body’s own defence system against blood clots – to be used on the global market for the treatment of complications resulting from thrombosis-related cardiovascular diseases.
Copyright © Proactive Investors 2019.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.